Use of anti-secretory medication: a population-based cohort study

Alimentary Pharmacology & Therapeutics
A LassenO B Schaffalitzky De Muckadell

Abstract

Total use of anti-secretory medication (H2 blockers and proton pump inhibitors) is increasing rapidly, but knowledge of factors related to the increasing use is sparse. To describe development in the use of anti-secretory medication between 1993 and 2002 at a population level. We extracted data on use of anti-secretory medication (H2-blockers and proton pump inhibitors) and ulcerogenic drugs, demographic data, and data on gastroscopy and endoscopically verified oesophagitis and peptic ulcer diagnoses, from three large population-based databases covering the County of Funen, Denmark 1990-2002 (population 470,000). Between 1993 and 2002 incidence of first time users was stable at 16.7/1000 persons/year. Total amount of consumed anti-secretory medication increased from 10.5 DDD/1000 persons/day to 25.2 DDD/1000 persons/day. Ninety per cent of the increase was related to long-term use of anti-secretory medication (> or = 180 DDD/patient/year). In 1993 21% of the anti-secretory medication was used by patients with oesophagitis, this increased to 28% in 2002. The proportion of medication used by peptic ulcer patients decreased from 29% in 1993 to 19% in 2002. Total use of anti-secretory medication increased as a result of more extens...Continue Reading

References

Dec 1, 1991·Statistics in Medicine·D G Altman
Apr 1, 1995·Alimentary Pharmacology & Therapeutics·S J Roberts, D N Bateman
Feb 1, 1995·Digestive Diseases and Sciences·R F McCloyA Walan
Nov 1, 1994·Scandinavian Journal of Gastroenterology·H ThorsB Thjodleifsson
Mar 26, 1994·BMJ : British Medical Journal·S D RyderA J Levi
Apr 1, 1996·Alimentary Pharmacology & Therapeutics·B M GoudieF E Murray
Apr 1, 1997·The Annals of Pharmacotherapy·J E McBrideY M Lam
Sep 3, 1998·Alimentary Pharmacology & Therapeutics·R M MartinS R Hilton
Nov 6, 1998·British Journal of Clinical Pharmacology·P McManusJ Lindner
Dec 24, 1998·Gut·H B el-Serag, A Sonnenberg
Jun 26, 1999·Alimentary Pharmacology & Therapeutics·R BoutetI MacKenzie
Dec 21, 2000·Journal of Clinical Pharmacy and Therapeutics·M NauntonM D Bleasel
Jul 27, 2001·Pharmacy World & Science : PWS·N M Walker, J McDonald
Dec 12, 2001·BMJ : British Medical Journal·J I WestbrookJ H McIntosh
Feb 28, 2002·Alimentary Pharmacology & Therapeutics·P MalfertheinerUNKNOWN European Helicobacter Pylori Study Group (EHPSG)
Sep 13, 2003·BMJ : British Medical Journal·Annmarie LassenOve B Schaffalitzky de Muckadell

❮ Previous
Next ❯

Citations

Oct 8, 2005·Surgical Endoscopy·N HodgsonD Franceschi
Aug 29, 2009·Digestive Diseases and Sciences·Ramalinga R KedikaStuart Jon Spechler
Sep 4, 2013·Best Practice & Research. Clinical Gastroenterology·Christina Reimer
Nov 30, 2007·Clinical Interventions in Aging·Carlo CalabreseGiulio Di Febo
Dec 14, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gati A GoelWilliam D Carey
Jul 26, 2011·Homeopathy : the Journal of the Faculty of Homeopathy·Marcus Zulian Teixeira
Mar 17, 2010·Best Practice & Research. Clinical Gastroenterology·Peter Bytzer
Jan 24, 2009·The American Journal of Geriatric Pharmacotherapy·Claudene J GeorgeJoseph S Ross
Jun 10, 2008·The Journal of Allergy and Clinical Immunology·Eva Untersmayr, Erika Jensen-Jarolim
Jul 27, 2005·Alimentary Pharmacology & Therapeutics·A S RaghunathR C McLoughlin
Jun 8, 2012·Alimentary Pharmacology & Therapeutics·P JuilleratJ R Korzenik
Oct 19, 2005·Gastroenterology·Annmarie LassenOve B Schaffalitzky de Muckadell
Aug 8, 2015·International Journal of Family Medicine·Jon Eik ZwislerOve B Schaffalitzky de Muckadell
May 2, 2014·The European Journal of General Practice·Peter HaastrupDorte Ejg Jarbøl
Sep 2, 2016·Therapeutic Advances in Gastroenterology·Anton PottegårdAnders B Lødrup
Mar 23, 2017·European Journal of Clinical Pharmacology·Emily Reeve, Sarah Hilmer
May 10, 2016·Journal of Clinical Gastroenterology·Hólmfridur HelgadóttirEinar S Björnsson
Sep 2, 2015·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Anna Budtz-LillyMarianne Rosendal
Apr 1, 2006·The American Journal of Gastroenterology·Annmarie LassenOve B Schaffalitzky de Muckadell
Oct 31, 2019·International Journal of Clinical Pharmacy·Camille LenoirVictoria Rollason
May 31, 2014·Scandinavian Journal of Gastroenterology·Anders LødrupPeter Bytzer
Oct 6, 2020·Frontiers in Pharmacology·Mária MatuzGyöngyvér Soós
Dec 18, 2020·Scandinavian Journal of Gastroenterology·Hólmfríður HelgadóttirEinar S Björnsson
Feb 17, 2021·BMJ Open Gastroenterology·Peter Fentz HaastrupSanne Rasmussen
Aug 3, 2021·Clinical Pharmacology in Drug Development·Joo Young NaJae-Yong Chung

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Postgraduate Medical Journal
Bisanth Thushila BatuwitageRuth Louise Bartlett
Journal of Clinical Pharmacy and Therapeutics
M NauntonM D Bleasel
© 2021 Meta ULC. All rights reserved